Tas, F. Et Al. 2004. Second-Line docetaxel and gemcitabine combination chemotherapy in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy: a phase II trial.. Medical oncology (Northwood, London, England) , vol.21, no.3 , 233-40.

Tas, F., Demir, C., Camlica, H., Ustuner, Z., & Topuz, E., (2004). Second-Line docetaxel and gemcitabine combination chemotherapy in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy: a phase II trial.. Medical oncology (Northwood, London, England) , vol.21, no.3, 233-40.

Tas, Faruk Et Al. "Second-Line docetaxel and gemcitabine combination chemotherapy in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy: a phase II trial.," Medical oncology (Northwood, London, England) , vol.21, no.3, 233-40, 2004

Tas, Faruk Et Al. "Second-Line docetaxel and gemcitabine combination chemotherapy in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy: a phase II trial.." Medical oncology (Northwood, London, England) , vol.21, no.3, pp.233-40, 2004

Tas, F. Et Al. (2004) . "Second-Line docetaxel and gemcitabine combination chemotherapy in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy: a phase II trial.." Medical oncology (Northwood, London, England) , vol.21, no.3, pp.233-40.

@article{article, author={Faruk TAŞ Et Al. }, title={Second-Line docetaxel and gemcitabine combination chemotherapy in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy: a phase II trial.}, journal={Medical oncology (Northwood, London, England)}, year=2004, pages={233-40} }